MiR-218 restrains proliferation of cervical cancer cells via targeted regulation of HMGB1/RAGE pathway.

CONCLUSIONS: MiR-218 inhibits the HMGB1/RAGE pathway to suppress the proliferation, migration and invasion of CC cells. PMID: 33455114 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research